RxDoctor Payments Data

Jason Musser, PA

Physician Assistant · Harrisburg, PANPI 1891884300

Payments from drug & device makers

$1,018in general payments, 2019–2025

Across 56 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$238
  • Novo Nordisk$150
  • GSK$126
  • Astellas Pharma US Inc$73
  • Dexcom, Inc.$56
  • Johnson & Johnson$48
  • plus $326 from 12 others

What the payments were for

  • Food & beverage$1,018100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,018 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$131,552
Medicare patients
168
Services billed
1,826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban145$95,833
Humira PenAdalimumab12$85,756
JardianceEmpagliflozin40$29,630
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$22,214
MounjaroTirzepatide19$21,645
Breo ElliptaFluticasone/Vilanterol42$17,032
XareltoRivaroxaban23$14,757
Nucynta ErTapentadol Hcl11$12,912
MyrbetriqMirabegron33$9,167
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$8,667
JanuviaSitagliptin Phosphate18$6,981
Atorvastatin Calcium460$6,864
Oxymorphone Hcl ErOxymorphone Hcl13$6,249
Metoprolol Succinate245$5,553
Gabapentin372$5,420

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$25$95,833145 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$126$47,91488 claims
Boehringer IngelheimJardiance$31$29,63040 claims
Lilly USA, LLCMounjaro$26$21,64519 claims
Johnson & JohnsonXarelto$48$14,75723 claims
Astellas Pharma US IncMyrbetriq$73$9,16733 claims
MerckJanuvia$35$6,98118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Harrisburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →